Dr Areli Karime Cuevas Ocampo, MD | |
1541 Kings Hwy, Shreveport, LA 71103-4228 | |
(318) 626-0000 | |
Not Available |
Full Name | Dr Areli Karime Cuevas Ocampo |
---|---|
Gender | Female |
Speciality | Pathology |
Experience | 16 Years |
Location | 1541 Kings Hwy, Shreveport, Louisiana |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134483597 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 324948 (Louisiana) | Secondary |
207ZN0500X | Pathology - Neuropathology | 324948 (Louisiana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Ochsner Lsu Health Shreveport | Shreveport, LA | Hospital |
Ochsner Lsu Health Shreveport-st Mary Medical Cent | Shreveport, LA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Lsu Health Sciences Center Shreveport Faculty Group Practice | 4082902721 | 529 |
News Archive
Excelitas Technologies® Corp., a global technology leader focused on delivering innovative, customized photonic solutions, today unveiled the new XLMii™ LED Fiber Optic Light Source for medical applications.
Carbapenemase-producing Enterobacteriaceae (also known as CPE) and Neisseria gonorrhoeae continue to be the most commonly reported organisms with critical resistances to antimicrobials across Australia, according to a national report released today.
Using ultraviolet disinfection technology to reduce the risk of hospital-acquired infections eliminated up to 97.7 percent of pathogens in operating rooms (ORs), according to a study published in the American Journal of Infection Control.
Emergent BioSolutions Inc. announced today that the U.S. Department of Justice and Federal Trade Commission granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 ("HSR Act"), as amended, with respect to the planned acquisition of Trubion Pharmaceuticals, Inc. by Emergent BioSolutions announced on August 12, 2010.
› Verified 1 days ago
Entity Name | Lsu Health Sciences Center Shreveport Faculty Group Practice |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1013374222 PECOS PAC ID: 4082902721 Enrollment ID: O20161012000307 |
News Archive
Excelitas Technologies® Corp., a global technology leader focused on delivering innovative, customized photonic solutions, today unveiled the new XLMii™ LED Fiber Optic Light Source for medical applications.
Carbapenemase-producing Enterobacteriaceae (also known as CPE) and Neisseria gonorrhoeae continue to be the most commonly reported organisms with critical resistances to antimicrobials across Australia, according to a national report released today.
Using ultraviolet disinfection technology to reduce the risk of hospital-acquired infections eliminated up to 97.7 percent of pathogens in operating rooms (ORs), according to a study published in the American Journal of Infection Control.
Emergent BioSolutions Inc. announced today that the U.S. Department of Justice and Federal Trade Commission granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 ("HSR Act"), as amended, with respect to the planned acquisition of Trubion Pharmaceuticals, Inc. by Emergent BioSolutions announced on August 12, 2010.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Areli Karime Cuevas Ocampo, MD 1512 W Kirby Pl, Shreveport, LA 71103-3822 Ph: (318) 626-0177 | Dr Areli Karime Cuevas Ocampo, MD 1541 Kings Hwy, Shreveport, LA 71103-4228 Ph: (318) 626-0000 |
News Archive
Excelitas Technologies® Corp., a global technology leader focused on delivering innovative, customized photonic solutions, today unveiled the new XLMii™ LED Fiber Optic Light Source for medical applications.
Carbapenemase-producing Enterobacteriaceae (also known as CPE) and Neisseria gonorrhoeae continue to be the most commonly reported organisms with critical resistances to antimicrobials across Australia, according to a national report released today.
Using ultraviolet disinfection technology to reduce the risk of hospital-acquired infections eliminated up to 97.7 percent of pathogens in operating rooms (ORs), according to a study published in the American Journal of Infection Control.
Emergent BioSolutions Inc. announced today that the U.S. Department of Justice and Federal Trade Commission granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 ("HSR Act"), as amended, with respect to the planned acquisition of Trubion Pharmaceuticals, Inc. by Emergent BioSolutions announced on August 12, 2010.
› Verified 1 days ago
Kshitij Satnamdas Arora, Pathology Medicare: Medicare Enrolled Practice Location: 1541 Kings Hwy, Shreveport, LA 71103 Phone: 318-626-0000 | |
Fleurette Wilheimina Abreo, MBBS Pathology Medicare: Medicare Enrolled Practice Location: 2915 Missouri Ave, Shreveport, LA 71109 Phone: 318-621-8820 Fax: 318-212-4189 | |
Dr. Fredric Thomas Siskron, MD Pathology Medicare: Medicare Enrolled Practice Location: 2915 Missouri Ave, Shreveport, LA 71109 Phone: 318-364-2000 | |
Sara Samadzadeh, M.D Pathology Medicare: Not Enrolled in Medicare Practice Location: 1501 Kings Hwy, Shreveport, LA 71103 Phone: 310-938-4285 | |
Dr. George K. Harrison, MD Pathology Medicare: Medicare Enrolled Practice Location: 2915 Missouri Ave, Shreveport, LA 71109 Phone: 318-364-2000 | |
Warren Donovan Grafton, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 1501 Kings Hwy, Department Of Pathology, Shreveport, LA 71103 Phone: 318-675-7737 Fax: 318-675-5666 | |
Dr. Maria-magdalena Georgescu, M.D., PH.D. Pathology Medicare: Medicare Enrolled Practice Location: 1501 Kings Hwy, Shreveport, LA 71103 Phone: 318-675-4929 |